What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Heart failure
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Heart failure and Surgery.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Endocrinology.
His Cardiology research incorporates themes from ACE inhibitor and Blood pressure.
Marc A. Pfeffer combines subjects such as Captopril and Pravastatin with his study of Myocardial infarction.
His Heart failure research is multidisciplinary, incorporating perspectives in Candesartan, Survival analysis, Proportional hazards model and Coronary artery disease.
His Surgery study combines topics from a wide range of disciplines, such as Diabetes mellitus, Stroke, Clinical trial and Risk factor.
His most cited work include:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels (6753 citations)
- EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL (5142 citations)
- Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (3936 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Heart failure, Myocardial infarction and Ejection fraction are his primary areas of study.
His Internal medicine study combines topics in areas such as Endocrinology and Surgery.
His Cardiology study frequently draws parallels with other fields, such as Valsartan.
As a part of the same scientific family, Marc A. Pfeffer mostly works in the field of Heart failure, focusing on Placebo and, on occasion, Randomized controlled trial.
His studies deal with areas such as Stroke, Captopril and Risk factor as well as Myocardial infarction.
He interconnects Diastole and Atrial fibrillation in the investigation of issues within Ejection fraction.
He most often published in these fields:
- Internal medicine (89.21%)
- Cardiology (71.01%)
- Heart failure (49.44%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (89.21%)
- Cardiology (71.01%)
- Heart failure (49.44%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Cardiology, Heart failure, Ejection fraction and Heart failure with preserved ejection fraction.
His work on Myocardial infarction, Hazard ratio and Spironolactone is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His Myocardial infarction research incorporates elements of Stroke, Framingham Risk Score and Sudden cardiac death.
His work carried out in the field of Cardiology brings together such families of science as Candesartan, Proportional hazards model and Renal function.
His Heart failure study incorporates themes from Kidney disease, Valsartan and Atrial fibrillation.
His research integrates issues of Interquartile range, Incidence, Cause of death, Clinical endpoint and Troponin T in his study of Ejection fraction.
Between 2015 and 2021, his most popular works were:
- Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. (1007 citations)
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (419 citations)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Myocardial infarction
Marc A. Pfeffer mainly investigates Internal medicine, Heart failure, Cardiology, Heart failure with preserved ejection fraction and Ejection fraction.
Marc A. Pfeffer works mostly in the field of Internal medicine, limiting it down to topics relating to Diabetes mellitus and, in certain cases, Acute coronary syndrome.
His research in Heart failure intersects with topics in Endocrinology and Baseline characteristics.
His studies in Cardiology integrate themes in fields like Candesartan, Aldosterone and Confidence interval.
His Ejection fraction research also works with subjects such as
- Diastole which connect with Speckle tracking echocardiography,
- Angiotensin receptor which connect with Heart disease.
His research investigates the connection between Myocardial infarction and topics such as Type 2 diabetes that intersect with issues in MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
